Prevalence, outcomes, and predictors of mortality among adult intensive care unit patients with sepsis at a Tertiary Hospital in Tanzania: A prospective cohort study
Prävalenz, Outcomes und Prädiktoren der Mortalität bei erwachsenen Intensivpatient:innen mit Sepsis in einem Tertiärkrankenhaus in Tansania: prospektive Kohortenstudie
PLOS One · 15.06.2026 · 21 (6) · e0351137
DOI: 10.1371/journal.pone.0351137 ↗Auf einen Blick
Bei 248 ICU-Patient:innen in Tansania war Sepsis häufig und mit hoher Mortalität verbunden. Frühe Antibiotikagabe war mit besserem Überleben assoziiert.
Fragestellung
Wie hoch sind Prävalenz, Outcomes und Mortalitätsprädiktoren bei erwachsenen Intensivpatient:innen mit Sepsis am Muhimbili National Hospital in Tansania?
Methode
Prospektive Kohortenstudie über 6 Monate (16. Mai bis 16. November 2023) auf der ICU des Muhimbili National Hospital; Sepsis nach Sepsis-3; Analyse mit modifizierter Poisson-Regression.
Ergebnisse
Die Sepsisprävalenz betrug 41,5 %. ICU-Mortalität 55,3 %. Unabhängig mit Mortalität assoziiert: multiple Komorbiditäten (aPR 3,35; 95 %-KI 1,20–9,32) und höherer SOFA-Score (aPR 7,08; 95 %-KI 3,48–14,4). Frühe Antibiotika: aPR 0,47; 95 %-KI 0,27–0,84.
Schlussfolgerung der Autor:innen
Die Studie zeigte eine hohe Prävalenz von Sepsis und sepsisbezogener Mortalität auf der ICU. Ein hoher SOFA-Score und multiple Komplikationen waren unabhängige Prädiktoren der Mortalität; frühe Antibiotikagabe war mit Überleben verbunden.
Kernaussagen
- Sepsisprävalenz auf der ICU: 41,5 %
- ICU-Mortalität: 55,3 %
- Frühe Antibiotikagabe war mit besserem Überleben assoziiert
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Kohortenstudie in der Zeitschrift PLOS One, online erschienen am 15.06.2026. Verfasst von Atala Jongo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, Muhimbili University of Health and Allied Sciences, Ilala, Dar es Salaam, Tanzania. Hauptthemen laut MEDLINE: Sepsis, Intensive Care Units. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Intensivpflege, Sepsis
Abstract (Originalsprache)
Background
Sepsis continues to pose a significant global health challenge, particularly in low- and middle-income countries, which face a disproportionate burden of sepsis and sepsis-related deaths. The estimated prevalence of sepsis and sepsis-related mortality is higher in intensive care units than in hospitals overall. The burden can be higher in tertiary referral centers that receive patients from different regions. This study aimed to determine the prevalence of sepsis, its outcomes, and the factors associated with these outcomes among adult patients admitted to the Intensive Care Unit (ICU) of the Muhimbili National Hospital (MNH) in Tanzania. Methodology This prospective cohort study was conducted over a period of six months from May 16 to November 16, 2023, at MNH. A total of 248 patients were admitted during the study period and screened for sepsis on admission or for the development of sepsis during their ICU stay. Sepsis was defined according to the Sepsis-3 criteria as a suspected infection with a Sequential Organ Failure Assessment (SOFA) score ≥2 within 24 h of ICU admission. Proportions were used for descriptive statistics, and modified Poisson regression analysis was used to identify independent predictors of mortality at a 95% confidence interval, with P < 0.05 indicating statistical significance.
Results
The prevalence of sepsis was 41.5%. The respiratory system was the most common source of infection (32%), and 22.3% of patients had more than one infection site. The ICU mortality rate was 55.3%, with 35% of patients developing systemic complications during their ICU stay. Factors independently associated with mortality included multiple comorbidities (aPR 3.35, 95% confidence interval [CI], 1.20–9.32; p = 0.021) and a higher SOFA score (aPR 7.08, 95% CI 3.48–14.4; p < 0.001). Early initiation of antibiotics was independently associated with improved survival (aPR 0.47, 95% CI 0.27–0.84; p = 0.011).
Conclusion
This study revealed a high prevalence of sepsis and sepsis-related mortality in the ICU. A high SOFA score and multiple complications were independent predictors of mortality. Early initiation of antibiotic therapy was an independent predictor of survival. This underscores the importance of early treatment, close monitoring, and aggressive management in patients with predictors of poor outcome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Anaesthesiology, Muhimbili University of Health and Allied Sciences, Ilala, Dar es Salaam, Tanzania.
- Department of Anaesthesiology, Pwani Regional Referral Hospital-Tumbi, Kibaha-Pwani, Tanzania.
ORCID-Profile: Atala Jongo
Zitieren
APA
Jongo, A., Lugazia, E., Mrutu, S., Omari, A. A., Msanga, H., Ndebea, A. S., & Amani, F. P. (2026). Prevalence, outcomes, and predictors of mortality among adult intensive care unit patients with sepsis at a Tertiary Hospital in Tanzania: A prospective cohort study. PLOS One, 21(6), e0351137. https://doi.org/10.1371/journal.pone.0351137
Vancouver
Jongo A, Lugazia E, Mrutu S, Omari AA, Msanga H, Ndebea AS, et al. Prevalence, outcomes, and predictors of mortality among adult intensive care unit patients with sepsis at a Tertiary Hospital in Tanzania: A prospective cohort study. PLOS One. 2026;21(6):e0351137. doi:10.1371/journal.pone.0351137
BibTeX
@article{Jongo2026,
author = {Jongo, Atala and Lugazia, Edwin and Mrutu, Salehe and Omari, Amina Abillah and Msanga, Hassani and Ndebea, Ansbert Sweetbert and Amani, Felix Paul},
title = {Prevalence, outcomes, and predictors of mortality among adult intensive care unit patients with sepsis at a Tertiary Hospital in Tanzania: A prospective cohort study},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {6},
pages = {e0351137},
doi = {10.1371/journal.pone.0351137}
}
EUVIMED